| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,445,894 | 1,569,712 | 1,357,483 | 1,006,692 | | Cost of Revenue | (852,255) | 852,255 |
-
| 3,782,536 | | | Gross Profit |
-
| 717,457 | 1,357,483 | (2,775,844) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,060,354 | 435,947 | 1,210,550 | (2,874,411) | | Non Recurring | 92,540 | 102,083 | 95,611 | 630,404 | | Others | 1,035,673 | 36,606 | 36,415 | (527,278) | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 81,227 | 142,821 | 14,907 | (4,559) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 109,582 | 142,821 | 14,907 | (4,559) | | Interest Expense | 1,959 | 11,630 | 14,766 | 17,854 | | Income Before Tax | 107,623 | 131,191 | 141 | (22,413) | | Income Tax Expense | 34,038 | 34,053 | (11) | (13,396) | | Minority Interest | (1,437) | (573) |
-
| 123 | | | | Net Income From Continuing Ops | 76,895 | 91,963 | (11,978) | (14,884) | | | Non-recurring Events | | Discontinued Operations | (1,441) |
-
| (440) |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 73,444 | 91,963 | (12,418) | (14,884) | | Preferred Stock And Other Adjustments |
-
| (20) | 20 |
-
| | | Net Income Applicable To Common Shares | $73,444 | $91,943 | ($12,398) | ($14,884) |
|
0.31% Nasdaq 
0.05%
Income Statement
